Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Fluticasone and formoterol (Flutiform®)
Fluticasone furoate & vilanterol (Relvar Ellipta®)		92mcg/22mcg - In line with COPD Guidance 92mcg/22mcg & 184mcg/22mcg - In line with asthma guidance
Fluticasone nebulised (Flixotide)
Fluticasone with Umeclidium and Vilanterol (Trelegy Ellipta)
Folic acid tablets
Formoterol
Fucibet cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Steroid potency - potent
Fucidin H cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Furosemide injection		Monitor potassium level. Indicated in pulmonary oedema. Need large doses in renal failure
Furosemide oral solution		Monitor potassium level. Indicated in pulmonary oedema. Need large doses in renal failure

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.